Long
CANO Cano Health Potential Buyout!

CANO Cano Health was trading at all time low last friday, $0.22!
Last year, I remember that following numerous reports suggesting a potential bid, Citigroup analysts have stated that if Humana or CVS Health were to acquire the primary-care provider Cano Health, they might value it at $14 per share.
With $2.74 Billions in revenue in 2022, I think Cano Health is too big to go bankrupt.
This might be an interesting buy opportunity, in my opinion!
Last year, I remember that following numerous reports suggesting a potential bid, Citigroup analysts have stated that if Humana or CVS Health were to acquire the primary-care provider Cano Health, they might value it at $14 per share.
With $2.74 Billions in revenue in 2022, I think Cano Health is too big to go bankrupt.
This might be an interesting buy opportunity, in my opinion!
Trade active
CANO went up from $0.22 to $0.338 after this Double Bottom. I`m still bullish on CANO.
Private SIGNALS patreon.com/PremiumOptionsSignals
Trading COURSE bit.ly/tradex
RESULTS bit.ly/TG10x
TradeNation bit.ly/t10X
CRYPTO partner.bybit.com/b/37880
BUY-SELL INDICATORS tradingindicators.store/
Trading COURSE bit.ly/tradex
RESULTS bit.ly/TG10x
TradeNation bit.ly/t10X
CRYPTO partner.bybit.com/b/37880
BUY-SELL INDICATORS tradingindicators.store/
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Private SIGNALS patreon.com/PremiumOptionsSignals
Trading COURSE bit.ly/tradex
RESULTS bit.ly/TG10x
TradeNation bit.ly/t10X
CRYPTO partner.bybit.com/b/37880
BUY-SELL INDICATORS tradingindicators.store/
Trading COURSE bit.ly/tradex
RESULTS bit.ly/TG10x
TradeNation bit.ly/t10X
CRYPTO partner.bybit.com/b/37880
BUY-SELL INDICATORS tradingindicators.store/
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.